Viewing Study NCT02874651


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-03-07 @ 7:05 PM
Study NCT ID: NCT02874651
Status: TERMINATED
Last Update Posted: 2022-01-11
First Post: 2016-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module